Biomarin Pharmaceutical - Registered Shares Intangible Assets

Biomarin Pharmaceutical - Registered Shares (BMRN) currently reports a intangible assets of $200M as of March 2026. That compares with $250M in the prior-year period — down 17.3% year over year. Use the charts on this page to explore Biomarin Pharmaceutical - Registered Shares's intangible assets history and peer comparisons.

Biomarin Pharmaceutical - Registered Shares's intangible assets decreased from $250M to $200M — a 17.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biomarin Pharmaceutical - Registered Shares reported $200M in intangible assets as of March 2026. That compares with $250M in the prior-year period — down 17.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biomarin Pharmaceutical - Registered Shares, and consider following BMRN for alerts when major investors trade the stock.

Biomarin Pharmaceutical - Registered Shares is classified in the Healthcare sector. On intangible assets, it currently shows $200M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BMRN with unrelated industries.